Business trending topics
1,360 results
Bridgewater, MA -- (SBWIRE) -- 05/20/2013 -- The online StockConsultant latest screen has found a biotech company that produces drugs for central nervous system disorders ACADIA Pharmaceuticals Inc. (NASDAQ …SBWire · 18 hours ago
In-depth coverageAcadia Pharmaceuticals, Inc. (NASDAQ: ACAD) announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance …StreetInsider · 5/14/2013
The Motley Fool
Baker Brothers bought 2mm shares, which is 25% of the 8mm shares issued (and if the greenshoe is exercised it would obv be a lower %). This is bullish, but let's not read too much into it- they need to buy into the deal to not be diluted down ...Yahoo! Finance · 9 hours ago
Jefferies Group reaffirmed their positive rating on shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) in a research note released on Monday morning, Stock Ratings Network reports. They currently have a $18.00 price target on the stock. ACADIA …Daily Political · ByJeff Wilder · 5/8/2013
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock, offered at a price to the public of $12.50 per share. The gross proceeds from this offering to ACADIA are ...4-traders · 5/15/2013
Stock Analysts’ ratings reiterations for Wednesday, May 8th: Credit Agricole SA (EPA: ACA) had its hold rating reiterated by analysts at Societe Generale. Societe Generale currently has a €7.80 ($10.26) price target on the stock. ACADIA …Zolmax News · 5/8/2013
SAN DIEGO--(BUSINESS WIRE)-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD ) today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock, offered at a price to the public of $12.50 per share. The gross …The Motley Fool · 5/15/2013
In order to become successful, you need to have information as it happens and understand how it plays out into future stock price. This is our expertise ... d=2013-05-16&s=CLF-AUY-ACAD-DELL Cliffs Natural Resources Inc. (NYSE: CLF) Did you want to …Stockhouse · 5/16/2013
(RTTNews.com) - ACADIA Pharmaceuticals Inc. ( ACAD) has priced the public offering of its common stock at $12.50 each. The company is selling 8 million shares in the offering, and the gross proceeds to ACADIA are expected to be $100 million ...NASDAQ · 5/15/2013
stock=PDLI&SubId=AW ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) a biopharmaceutical company that focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders closed up in its …Marketwatch · 5/14/2013
You might also like
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback